These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16413138)

  • 1. Should slow coronary flow be considered as a coronary syndrome?
    Li JJ; Wu YJ; Qin XW
    Med Hypotheses; 2006; 66(5):953-6. PubMed ID: 16413138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is slow coronary flow associated with inflammation?
    Li JJ; Xu B; Li ZC; Qian J; Wei BQ
    Med Hypotheses; 2006; 66(3):504-8. PubMed ID: 16288834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The coronary slow flow phenomenon--a new coronary microvascular disorder.
    Beltrame JF; Limaye SB; Horowitz JD
    Cardiology; 2002; 97(4):197-202. PubMed ID: 12145474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary slow-flow causing transient myocardial hypoperfusion in patients with cardiac syndrome X: long-term clinical and functional prognosis.
    Fragasso G; Chierchia SL; Arioli F; Carandente O; Gerosa S; Carlino M; Palloshi A; Gianolli L; Calori G; Fazio F; Margonato A
    Int J Cardiol; 2009 Oct; 137(2):137-44. PubMed ID: 18762343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins may be beneficial for patients with slow coronary flow syndrome due to its anti-inflammatory property.
    Li JJ; Zheng X; Li J
    Med Hypotheses; 2007; 69(2):333-7. PubMed ID: 17215087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ST elevation during treadmill exercise test in a young patient with slow coronary flow: a case report and review of literature.
    Celik T; Iyisoy A; Kursaklioglu H; Yuksel C; Turhan H; Isik E
    Int J Cardiol; 2006 Sep; 112(2):e1-4. PubMed ID: 16766061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The coronary slow flow phenomenon: a new cardiac "Y" syndrome?
    Leone MC; Gori T; Fineschi M
    Clin Hemorheol Microcirc; 2008; 39(1-4):185-90. PubMed ID: 18503124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is acute myocardial infarction a localized or rather a global coronary phenomenon?
    Deleanu D; Chreih RM; Modavu I; Zarma L; Bucşa A; Platon P; Croitoru M; Postu M; Ginghină C
    Rom J Intern Med; 2006; 44(3):261-71. PubMed ID: 18386605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary angiographic findings in acute coronary syndrome--disease progression, coronary plaque disruption and etiological mechanism].
    Nishimura S; Kato K
    Nihon Naika Gakkai Zasshi; 1999 Sep; 88(9):1719-22. PubMed ID: 10581752
    [No Abstract]   [Full Text] [Related]  

  • 10. The angiographic and clinical benefits of mibefradil in the coronary slow flow phenomenon.
    Beltrame JF; Turner SP; Leslie SL; Solomon P; Freedman SB; Horowitz JD
    J Am Coll Cardiol; 2004 Jul; 44(1):57-62. PubMed ID: 15234407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "slow coronary flow" phenomenon: evidence of preserved coronary flow reserve despite increased resting microvascular resistances.
    Fineschi M; Bravi A; Gori T
    Int J Cardiol; 2008 Jul; 127(3):358-61. PubMed ID: 17651842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epicardial and microvascular reperfusion with primary percutaneous coronary intervention.
    Bolognese L; Falsini G; Liistro F; Angioli P; Ducci K
    Ital Heart J; 2005 Jun; 6(6):447-52. PubMed ID: 16008148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PET perfusion and vasodilator function after angioplasty for acute myocardial infarction.
    Stewart RE; Miller DD; Bowers TR; McCullough PA; Ponto RA; Grines CL; O'Neill WW; Juni JE; Safian RD
    J Nucl Med; 1997 May; 38(5):770-7. PubMed ID: 9170444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute coronary syndrome: stages of diagnosis determining treatment policy].
    Gogin EE
    Ter Arkh; 2001; 73(4):5-11. PubMed ID: 11494448
    [No Abstract]   [Full Text] [Related]  

  • 15. Lack of evidence for small vessel disease in a patient with "slow dye progression" in the coronary arteries.
    Van Lierde J; Vrolix M; Sionis D; De Geest H; Piessens J
    Cathet Cardiovasc Diagn; 1991 Jun; 23(2):117-20. PubMed ID: 2070396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [To surpass coronary luminology with interventional physiology].
    Kern MJ
    Arch Mal Coeur Vaiss; 1997 May; 90 Spec No 2():41-50. PubMed ID: 9295926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Specific features of the clinical course and angiographic pattern in chronic coronary artery occlusion].
    Savchenko AP; Abdullin MI; Matchin IuG; Naumov VG
    Vestn Rentgenol Radiol; 2000; (4):4-10. PubMed ID: 11048494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of intra-coronary injection of anisodamine on the slow-reflow phenomenon in patients with acute myocardial infarction after percutaneous coronary intervention].
    Wei YY; Fu XH; Liu J
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Apr; 28(4):295-9. PubMed ID: 18543478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does coronary slow flow phenomenon lead to myocardial ischemia?
    Tatli E; Yildirim T; Aktoz M
    Int J Cardiol; 2009 Jan; 131(3):e101-2. PubMed ID: 17931724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The no-flow phenomenon during diagnostic coronary angiography.
    Zavala-Alarcon E; Cecena F; Little R; Bant A; Van Poppel S; Patel R
    Cardiovasc Revasc Med; 2005; 6(3):126-32. PubMed ID: 16275610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.